Article · 2013
Editor
Gary Guishan Xiao
Director, Genomics and Functional Proteomics Laboratories, USA
About
As published by the journal they serve.
Gary Guishan Xiao is a Director of the Functional Genomics and Proteomics laboratories at the Creighton University. Osteoporosis Research Center, is an internationally recognized expert in the field of proteomics and metabolomics of cancers and bone disease. Dr. Xiao earns his Ph.D. in molecular computational biology about a dozen years ago, focusing on structural modeling of ligand-enzyme interaction and prediction of protein refolding pathways during protein translational process. Dr. Xiao had his postdoctoral research trained in Baylor College of Medicine and UCLA, focusing on pharmacokinetics and biochemistry of non-steroid inflammatory drugs such as aspirin-derivatives and their target, human prostaglandin H synthases H1 and H2, and cell cycle regulation, especially, the role of c-Myc in cardiac termination differentiation. Dr. Xiao’s research at harbor UCLA medical Center and City of Hope National Cancer Center were highly focused on genomic and proteomic interpretations of diet-induced obesity/diabetes and its complications such cancers and osteoporosis. Dr. Xiao joined Osteoporosis Research Center at the Creighton University Medical Center since 2007. Dr. Xiao has been regular reviewer or ad hoc reviewer for several medial journals, different funding agency such as NIH and several journal Editorial Board members.
Research interests
Qualifications
PhD
Journals they serve
The seats these journals name them in.
- Cancer Science & TherapyEditor
- Cancer Science & TherapyEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2011
MicroRNAs induce tamoxifen sensitivity by down-regulation of estrogen receptor alpha signaling in breast cancer
Article · 2011
MicroRNAs induce tamoxifen sensitivity by down-regulation of estrogen receptor alpha signaling in breast cancer
Article · 2015
Regulation of miR-34a-SIRT1 axis reduced breast cancer stemness
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.